JALM Talk Podcast cover art

All Episodes

JALM Talk Podcast — 167 episodes

#
Title
1

An Overview of Allowable Total Error in the Clinical Laboratory

2

Toward Sustainable Clinical Chemistry: Waste Quantification and Reduction Strategies from Testing on 4 Commonly Used Automated Analyzers

3

Design and Analytical Evaluation of an Immunoassay for Long Forms of Cardiac Troponin T

4

Assessing and Resolving Findings of Sex Chromosome Discordance in Genetic Testing

5

ADLM Guidance Document on Laboratory Testing for Drugs of Misuse to Support the Emergency Department

6

Concurrent Anti-PR3 Immunoassay and cANCA Indirect Immunofluorescence Testing Provide Complementary Information for Clinical Laboratory Detection of Antineutrophil Cytoplasmic Antibodies

7

Blood Utilization and Waste Following Implementation of Thromboelastography

8

ADLM Guidance Document on Coagulation Testing in Patients Using Direct Oral Anticoagulants

9

Handling Hemolytic Blood Samples from High-Risk Clinical Areas: A Call to Action

10

SBC-SHAP: Increasing the Accessibility and Interpretability of Machine Learning Algorithms for Sepsis Prediction

11

MedPromptExtract (Medical Data Extraction Tool): Anonymization and High-Fidelity Automated Data Extraction Using Natural Language Processing and Prompt Engineering

12

Rapid Whole-Genome Sequencing as a First-Line Test Is Likely to Significantly Reduce the Cost of Acute Care in a Private Payer System

13

The 2024 PhD Board-Certified Clinical Chemist Compensation Survey

14

Fetal Fraction Methodologies and Their Clinical Use: Results of a College of American Pathologists Exercise

15

Is the 99th Percentile Cutoff Still Relevant? A Single-Center Assessment of Different Thresholds for Diagnosing Antiphospholipid Syndrome

16

Price Variability of Eight Common Laboratory Tests across All Licensed Tennessee Hospitals

17

Comparison of 2 Sets of Immunoassays Used in Modified 2-Tiered Testing Algorithms for the Diagnosis of Lyme Disease

18

High-Sensitivity Cardiac Troponin Assays: From Implementation to Resource Utilization and Cost Effectiveness

19

Total Prostate-Specific Antigen (PSA) Testing in Capillary Samples: Proof-of-Principle and Feasibility Study for Home Self-Testing for Prostate Cancer

20

Clinician-Ordered Peripheral Smear Review by a Pathologist Has Low Clinical Utility—A Reference Laboratory Perspective

21

Developing Benchmarking Metrics for Appropriate Ordering of Vitamin D, Thyroid Testing, and Iron Workups

22

Survey of Laboratory Stewardship Governance at US Academic Medical Centers

23

One Size Fits Small: The Narrow Utility for Plasma Metagenomics

24

An Introduction to the Complete Blood Count for Clinical Chemists: Platelets

25

Cardiac Troponin to Adjudicate Subclinical Heart Failure in Diabetic Patients and a Murine Model of Metabolic Syndrome

26

Recent Recall of Iron Reagent—Investigation of Potential Reagent Contamination and Assay Improvement Strategy

27

Glycated Albumin to Predict Adverse Neonatal Outcomes among Women with Diabetes and Overweight or Obese Body Mass Index

28

ADLM Guidance Document on the Measurement and Reporting of Lipids and Lipoproteins

29

Performance of fentanyl immunoassays in an ED patient population

30

Breaking the Chain: Navigating the Pitfalls of Total Laboratory Automation

31

Utility of Cystatin C-based Equation for the Estimation of Glomerular Filtration Rate in a Pediatric Population

32

Implementation of a Self-Audit Tool Improves Regulatory Compliance for Point-of-Care Respiratory Virus Testing in the Emergency Department

33

ADLM Guidance Document on Laboratory Diagnosis of Respiratory Viruses

34

Not Carfentanil—A Case of Unexpected Xylazine Detection

35

A Mathematical Algorithm for Dried Blood Spot Quality Assessment and Results concerning Quality from a Newborn Screening Program

36

Development of a Rapid Qualitative Screen for Anticoagulant Presence

37

Immunoassay Testing of Alpha-Gal Specific Immunoglobulin-E: Data from a National Reference Laboratory

38

The Role of Artificial Intelligence for Providing Scientific Content for Laboratory Medicine

39

Elucidating the Clinical Interpretation and Impact of a Positive Plasma Cell-Free DNA Metagenomics Test Result—A Single Center Retrospective Study

40

Point: The Need for Additional FDA Regulations in Laboratory Medicine; Counterpoint: Why the FDA Should Not Regulate Laboratory-Developed Tests

41

Clinical Utility and Long-Term Feasibility of Exome and Genome Reanalysis: From the Perspectives of a Clinical Laboratory

42

When Positive is Negative: Health Literacy Barriers to Patient Access to Clinical Laboratory Test Results

43

Robust Response of the Clinical Laboratory to the COVID-19 Pandemic despite Significant Challenges

44

Analytical Performance Evaluation of Three Point-of-Care CBC Analyzers for Management of Clozapine Therapy in Ambulatory Psychiatry Clinics

45

Cardiac Troponin T Degradation in End-Stage Renal Disease Patients Appears to Occur in Vivo

46

Global Heatwaves Threaten Integrity of Patient Test Results: A Dire Warning for the Lab Medicine Community

47

Raising the Dead Volume: Analysis of Microsamples Diluted and Corrected with Near Infrared Tracer

48

AACC/NKF Guidance Document on Improving Equity in Chronic Kidney Disease Care

49

Inverse Associations between Measures of Adiposity and Glycated Albumin in US Adults, NHANES 1999–2004

50

Pediatric Reference Value Profiling of Essential Trace and Toxic Elements in Healthy Children and Adolescents Using High-Resolution and Triple Quadrupole Inductively Coupled Plasma Mass Spectrometry

51

Clinical Laboratory Approaches for Diagnoses of Sleep-Disordered Breathing and ADHD-Like Behavior in Children

52

AACC Guidance Document on the Clinical Use of Procalcitonin

53

Clinical Validation of the sFlt-1:PlGF Ratio as a Biomarker for Preeclampsia Diagnosis in a High-Risk Obstetrics Unit

54

Comparison of a Novel Thin-Walled 25-gauge Needle Push Button Blood Collection Set to a Standard 23-gauge Needle in a Cancer Patient Population

55

AACC Guidance Document on Cervical Cancer Detection: Screening, Surveillance, and Diagnosis

56

Deceptively Simple: Can Urine Samples from CLIA-Waived Urine Drug Screen Devices Be Reused for Confirmatory Testing?

57

On Developing Better Practices for Reproducible Data Analysis in Laboratory Medicine

58

End to End Data Automation for Pooled Sample SARS-CoV-2 Using R and Other Open-Source Tools

59

Risk Analysis for Quality Control Part 2: Theoretical Foundations for Risk Analysis

60

CRP and High-Sensitivity CRP: "What's in a Name?"

61

Overprediction of Carbapenemase-Containing Isolates by an Automated AST Instrument's Computer Algorithm

62

It's VALID, but Is It Rational?

63

Decreasing the Lower Limit of Quantitation for Urine Albumin Improves Clinical Utility

64

The Biological Variability of Plasma Ceramides in Healthy Subjects

65

Reference Intervals for Clinical Chemistry Analytes for Transgender Men and Women on Stable Hormone Therapy

66

AACC Guidance Document on the Use of Point-of-Care Testing in Fertility and Reproduction

67

Point-of-Care: Roadmap for Analytical Characterization and Validation of a High Sensitivity Cardiac Troponin I Assay in Plasma and Whole Blood Matrices

68

Contemporary Challenges in Clinical Flow Cytometry: Small Samples, Big Data, Little Time

69

Predicting Direct-Specimen SARS-CoV-2 Assay Performance Using Residual Patient Samples

70

Utilizing Longitudinal Within-Individual Changes of Serum Creatinine, Cystatin C, and/or eGFR to Optimize Clinical Sensitivity and Eliminate Race and Gender Corrections

71

Impact of the AACC Global Laboratory Quality Initiative in Partnership with Professional Societies and Universities in Latin America and the Caribbean

72

Engaging Laboratory Staff in Stewardship: Barriers Experienced by Medical Laboratory Technologists in Canada

73

Development and Implementation of One-Step, Broad-Spectrum, High-Sensitivity Drug Screening by Tandem Mass Spectrometry in a Pediatric Population

74

Evaluation of Three Anti-SARS-CoV2 Serologic Immunoassays for Post-vaccine Response

75

Correlation of ANA Characteristics with pANCA IFA Interference

76

Anti-Nuclear Antibody Quantitation: Calibration and Harmonization Adjustment via Population Interrogation

77

The 2021 PhD Board-Certified Clinical Chemist Compensation Survey

78

AACC Guidance Document on Laboratory Investigation of Acute Kidney Injury

79

More than Just Contaminants: Frequency and Characterization of Polymicrobial Blood Cultures from a Central Clinical Microbiology Laboratory Serving a Large Healthcare System

80

Validation of a Commercial Reagent for the Depletion of Biotin from Serum/Plasma: A Rapid and Simple Tool to Detect Biotin Interference with Immunoassay Testing

81

Use of a Daratumumab-Specific Immunofixation Assay to Assess Possible Immunotherapy Interference at a Major Cancer Center: Our Experience and Recommendations

82

A Multicenter Evaluation of a Point-of-Care Blood Glucose Meter System in Critically Ill Patients

83

Rapid Quantification of Plasma Creatinine Using a Novel Kinetic Enzymatic Assay

84

AACC Guidance Document on Laboratory Testing for the Assessment of Preterm Delivery

85

How SARS-CoV-2 Transformed the Clinical Laboratory: Challenges and Lessons Learned.

86

Plasma Protein Profiling by Proximity Extension Assay Technology Reveals Novel Biomarkers of Traumatic Brain Injury – A Pilot Study

87

Engaging Pathology Residents in Clinical Chemistry: The Essential Ingredient Is a Committed Teacher

88

Comparison of Two Automated Immunoassays for the Detection of SARS-CoV-2 Nucleocapsid Antibodies

89

A Shared Diagnostic Stewardship Approach toward Improving Autoimmune Encephalopathy Send-out Testing Utilization

90

On the Basis of Race: The Utility of a Race Factor in Estimating Glomerular Filtration

91

The Medical Students' Perspective of Health Disparities and a Raced Based Curriculum: Addressing Disparities in Medical Education

92

Recognizing Laboratory Medicine's Collaborative Role in Identifying and Eliminating Health Disparities

93

Impact of COVID-19 Pandemic on Laboratory Utilization

94

Ten-Month Evaluation of the Routine Application of Patient Moving Average for Real-Time Quality Control in a Hospital Setting

95

Liquid biopsy to detect circulating tumor cells: is it ready for a value proposition in laboratory medicine?

96

Detection of Intravascular Hemolysis in Newborns Using Urinary Carbonic Anhydrase I Immunoreactivity

97

Intelligent Liver Function Testing: Working Smarter to Improve Patient Outcomes in Liver Disease

98

Demand for Interpretation of a Urine Drug Testing Panel Reflects the Changing Landscape of Clinical Needs; Opportunities for the Laboratory to Provide Added Clinical Value

99

Current Practices When Reporting Quantitative Human Chorionic Gonadotropin Test Results

100

Correlation of Chemical Urinalysis to Microscopic Urinalysis and Urine Culture: Implications for Reflex Urinalysis Workflows

101

Unexpected Troponin Elevation in a Patient Treated with Atorvastatin

102

AACC Guidance Document on Biotin Interference in Laboratory Tests

103

Volumetric Microsampling of Capillary Blood Spot vs Whole Blood Sampling for Therapeutic Drug Monitoring of Tacrolimus and Cyclosporin A: Accuracy and Patient Satisfaction

104

Bridging the Gap: Acute Neurology and a Metabolic Acidosis

105

Cannabinol (CBN) Cross-Reacts with Two Urine Immunoassays Designed to Detect Tetrahydrocannabinol (THC) Metabolite

106

The 2018 AACC/SYCL PhD Clinical Chemist Compensation Survey

107

Unleashing the Power of Laboratory Developed Tests: Closing gaps in COVID diagnosis and beyond

108

Contingency planning in the clinical laboratory: lessons learned amidst COVID-19

109

A Laboratory Risk Assessment during the Coronavirus (COVID-19) Pandemic

110

Clinical Laboratory Detection of a High-Level Hemoglobin Abnormality in a Patient with Suspected Recreational Drug Ingestion

111

Rapid Diagnosis, Triage, and Treatment of a 59-Year-Old Man with Sudden-Onset Right-Sided Weakness and Difficulty Speaking

112

Bad Tests Die Slowly: The Myelin Basic Protein Example

113

Reproducible Research and Reports with R

114

Practical Approach to Eliminate Bilirubin Interference in Icteric Samples for Creatinine Measurement

115

Laboratory Test Utilization and Repeat Testing for Inpatients of Age 80 and Over in Australia

116

A Multicenter Assessment of the Sensitivity and Specificity for a Single High-Sensitivity Cardiac Troponin Test at Emergency Department Presentation for Hospital Admission

117

Development of Reference Materials for Noninvasive Prenatal Aneuploidy Testing by Massively Parallel Sequencing: A Proof-of-Concept Study

118

Isotyping of Paraprotein Irresolvable by Routine Immunofixation Electrophoresis

119

D-dimer: Common Assay, Challenges Abound, Caution Advised

120

It's Not Just a Needlestick: Exploring Phlebotomists' Knowledge, Training, And Use of Comfort Measures in Pediatric Care to Improve the Patient Experience

121

Analytical Concordance of Diverse Point-of-Care and Central Laboratory Troponin I Assays

122

Case of Sudden Acute Coma Followed by Spontaneous Recovery

123

AUC-Based Monitoring of Vancomycin: Closing the Therapeutic Window

124

Clinical Effect of Expedited Pathogen Identification and Susceptibility Testing for Gram-Negative Bacteremia and Candidemia by Use of the Accelerate PhenoTM System

125

Elimination of 72-Hour Quantitative Fecal Fat Testing by Restriction, Laboratory Consultation, and Evaluation of Specimen Weight and Fat Globules

126

Algorithms Used in Ovarian Cancer Detection: A Minireview on Current and Future Applications

127

The (Sun)Light and Dark of 25-Hydroxyvitamin D Testing

128

Creation of a Professional Development Program for Women in a Major US Medical School Pathology Department

129

Interventions That Can Help Reduce Diagnostic Errors

130

False Positive Carbamazepine Results by Gas-Chromatography Mass Spectrometry and VITROS 5600 Following a Massive Oxcarbazepine Ingestion

131

Keeping Up with Fentanyl: Failure to Do So Is Not an Option

132

Automated Laboratories: When Technology Needs a Human Touch

133

Thrombophilia: Women-Specific Reference Ranges Can Prevent Misdiagnosis in Women

134

High-Throughput LC-MS/MS Method for Determination of the Alcohol Use Biomarker Phosphatidylethanol in Clinical Samples by Use of a Simple Automated Extraction Procedure—Preanalytical and Analytical Conditions

135

Genotype–Phenotype Correlations of G6PDt Variants Throughout an Activity Distribution

136

Expanding the Utility of High-Sensitivity Dried Blood Spot Immunoassay Testing with Single Molecule Counting

137

A Paradigm Shift: Considerations in Prenatal Cell-Free DNA Screening

138

Medical Cannabis and Pain Management

139

Reflections of Two Pain Medicine Clinicians in the Era of the Opioid Crisis

140

Pharmacogenetics of Opioid Use and Implications for Pain Management

141

Executive Summary: American Association of Clinical Chemistry Laboratory Medicine Practice Guideline—Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients

142

Therapeutic Monoclonal Antibodies in the Clinical Laboratory

143

Biological Variation of Donor-Derived Cell-Free DNA in Renal Transplant Recipients: Clinical Implications

144

The Importance of Verifying Reference Intervals for Calculated Results

145

Transforming Laboratory Utilization Review into Laboratory Stewardship: Guidelines by the PLUGS National Committee for Laboratory Stewardship

146

Sandwich Immunoassay for Bioactive Plasma Adrenomedullin

147

Automated Sample Preparation Enables LC-MS/MS as a Routine Diagnostic Analysis for Serum Testosterone

148

The Era for High-Sensitivity Cardiac Troponin Has Begun in the US (Finally)

149

Serum Free Light Chain (FLC) Analysis: A Guiding Light in Monoclonal Gammopathy Management

150

Creation of a Universal Sample Bank for Determining the 99th Percentile for Cardiac Troponin Assays

151

Comparison of the Alere i and BD Veritor Assays for the Rapid Detection of Influenza A and B Viruses

152

Effect of Preanalytical Factors on the Stability of Maternal Serum Biomarkers and Calculated Risk for Trisomy 21, Trisomy 18, and Open Neural Tube Defect

153

Sickle Cell Trait in the Blood Supply

154

Quality Monitoring Approach for Optimizing Antinuclear Antibody Screening Cutoffs and Testing Work Flow

155

Myocardial Ischemia on Exercise Stress Echocardiography Testing Is Not Associated with Changes in Troponin T Concentrations

156

Are Heart Failure Management Recommendations and Guidelines Followed in Laboratory Medicine in Europe and North America?

157

Point-of-Care vs Central Lab "Discrepancies"

158

To Delta Check or Not to Delta Check? That Is the Question

159

The Importance of Effective Communication

160

Defying Gravity

161

Persistently Elevated Human Chorionic Gonadotropin in a Menopausal Woman

162

Lipoprotein Biomarkers and Risk of Cardiovascular Disease

163

Moving Latin American Laboratories Forward by Giving Back

164

α-Glutathione S-Transferase: A New Biomarker for Liver Injury?

165

The Food and Drug Administration: Overseeing, Overarching, Overreaching

166

Analytical and Clinical Evaluation of the NOWDiagnostics ADEXUSDx Human Chorionic Gonadotropin Test Using Whole Blood

167

Utility of Antinuclear Antibody Screening by Various Methods in a Clinical Laboratory Patient Cohort